Economic Impact of Coverage Expansion for Non-invasive Prenatal Testing Through a Performance-Based Risk-Sharing Agreement-Reference-Cited by-同舟云学术

Economic Impact of Coverage Expansion for Non-invasive Prenatal Testing Through a Performance-Based Risk-Sharing Agreement

Published:2021-03-10 Issue:3 Volume:5 Page:449-458
ISSN:2509-4262
Container-title:PharmacoEconomics - Open
language:en
Short-container-title:PharmacoEconomics Open

Author:

Quinlan Taryn A. G.,Schroeder Brock,Kwon Sue,Barlow Jane F.,Sherman Michael S.,Anderson Heather D.,Wright Garth,McQueen R. Brett^ORCID

Funder

Illumina

Real Endpoints, LLC

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Health Policy,Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s41669-021-00261-y.pdf

Reference31 articles.

1. Garrison LP, et al. Performance-based risk-sharing arrangements—good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force. Value Health. 2013;16(5):703–19.

2. Carlson JJ, et al. Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers. Health Policy. 2010;96(3):179–90.

3. Garrison LP, et al. Private sector risk-sharing agreements in the United States: trends, barriers, and prospects. Am J Manag Care. 2015;21(9):632–40.

4. Carlson JJ, Chen S, Garrison LP. Performance-based risk-sharing arrangements: an updated international review. Pharmacoeconomics. 2017;35(10):1063–72.

5. Gil MM, et al. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2017;50(3):302–14.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conversations With the Editors: Stewardship in Genomic Medicine—Insights From Health Care Payers at the Forefront of Clinical Innovation and Partnerships;Clinical Therapeutics;2023-08

2. Factors involved in the decision to decline prenatal screening with noninvasive prenatal testing (NIPT);Prenatal Diagnosis;2022-09-23

3. Non-invasive prenatal testing in mitigating concerns from invasive prenatal diagnostic testing: retrospective assessment of utility in an academic healthcare system in the US;BMJ Open;2022-06

4. Multicancer Screening Tests: Anticipating And Addressing Considerations For Payer Coverage And Patient Access;Health Affairs;2022-03-01

5. Coverage expansion for non-invasive prenatal testing: clinical benefits, modest budget increase;PharmacoEconomics & Outcomes News;2021-03